retatrutide phase 2 nejm 2023 weight loss percent 48 weeks 🚨 Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and type diabetes. 📊 Mean body change at 80 weeks: ⬇️ Retatrutide vs Tirzepatide Compared |

Body composition changes show large fat mass reductions but also measurable lean mass loss that scales with total weight lost

Understanding this helps set realistic expectations about when results are likely to emerge

Pregnant and breastfeeding women are generally advised against using Semaglutide, as its safety during pregnancy has not been established

If you or a loved one suffered from severe stomach paralysis, bowel obstruction, ileus, or other health issues after taking Ozempic, you may be eligible to file an Ozempic lawsuit against the drug makers

But if its been more than 5 days since your missed dose, skip the missed dose and go back to your regular dosing schedule

Hence, if more individuals change from bile acid sequestrant treatment to GLP-1RA treatment than vice versa, the GLP-1RA is deemed the superior treatment